Cancer Scientist's Secret Links to Drug Firms
15892
By ED HARRIS  A RENOWNED British scientist failed to disclose that he was being paid by a chemical company for more than 20 years while investigating cancer risks in the industry, it emerged today.
271866
New studies are raising questions about whether drugs that have been used by millions of cancer patients might actually be harming them.
181860
Platforms have the potential to develop multiple drugs for a company.
619835
Scientists at the University of Cambridge develop new treatments for cancer.
509437
A team of Korean scientists have found a way to solve the cancer paradox of why aging cells with reduced ability to proliferate are susceptible to cancer, characterized by uncontrolled cell growth.
750125
Harvard researchers are developing the first drug that specifically targets cancer stem cells.
668672
MONDAY, Feb. 26 (HealthDay News) -- Breast cancer treatment trials that are funded by drug companies are more likely to show positive results than studies sponsored by other sources, new research suggests.
550204
CHICAGO/NEW YORK  - When it comes to the price tag  for the newest biotechology drugs for cancer and other  hard-to-treat diseases, the sky is likely to remain the limit,  insurers, drugmakers and industry watchers say.
732990
Researchers who found a genetic pattern that predicts who will be helped by a revolutionary new lung cancer drug said on Monday they were looking for patients to help them confirm their findings.
518363
The treatment that more cancer patients receive may one day depend on their genes
10866
Scientists believe they have found a way to spot which breast and ovarian cancers are most likely to be fatal.
476699
Scientists believe they have found a way to make prostate cancer treatment more effective.
129442
Dr. Marcia Angell, a pathologist and former editor of The New England Journal of Medicine, is taking on the American pharmaceutical industry.
26608
German and Swiss drug makers Schering and Novartis are developing a new anti-cancer drug with annual sales potential of up to two billion euros (2.7 billion dollars), Schering chief Hubertus Erlen said.
421686
Five years ago, Portland&#39;s Dr. Brian Druker told a gathering of blood scientists about a few dozen cancer patients who were taking an obscure new drug with surprising success.
330991
Doctors are missing key information they need to make decisions for cancer patients because some drug companies are not publishing clinical trials.
129745
A painstaking scan of the DNA of  tumor cells shows hundreds of previously unsuspected genes are  involved in cancer, researchers said on Wednesday in a finding  that offers new ways to fight the disease.